In October 2020, researchers at Columbia University began enrolling volunteers who were physically dependent on opioid drugs for a new clinical trial—the world’s first to test a vaccine targeting ...

Vertex Pharmaceuticals (VRTX)’ opioid alternative ... Moderna (MRNA) said in June that its experimental combination vaccine ...

This would reverse progress toward curbing drug shortages. AstraZeneca scrapped plans to invest $558.3 million in its vaccine ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

The company has had a tough few years, amid flatlining reimbursement for dispensing prescriptions, falling demand for vaccines and tests ... resolve its role in the opioid crisis, which has ...

A chunk of pharma companies' roughly $50 billion opioid settlements is being designated ... and go to your garage and create a smallpox vaccine,” Papa said. “It really requires very specific ...

But be safe. Enjoy, and see you soon. … Vertex Pharmaceuticals won approval from the U.S. Food and Drug Administration for a non-opioid pain drug, clearing the way for the rollout of a product ...